Clinical study of AdV-tk radiogene therapy for glioma
Small Business Information
ADVANTAGENE, INC., 160 PAULSON RD, WABAN, MA, 02468
AbstractDESCRIPTION (provided by applicant): Malignant gliomas have a very poor prognosis with median survival measured in months rather than years. It is a disease with great need of novel therapeutic approaches. Within cancer gene therapy the use of adenovir
* information listed above is at the time of submission.